Cafepharma Today

June 6 2025 - Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
Novartis presses court for hasty decision in long-running Entresto patent feud with MSN
'Not a horse and pony show': At FDA cell and gene roundtable, officials look for ways to cut red tape
With ADCs on the rise, drugmakers embrace a new oncology pillar
Bayer trial combines two top drugs for kidney disease
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer's Plan B In Immuno-Oncology: Collaboration With Smaller Companies
Seeking Alpha
Wednesday, June 25, 2014 - 5:16pm
tags:
Pfizer, cancer immunotherapy, Cellectis
Left Behind In The Rally: Pfizer
Seeking Alpha
Wednesday, June 25, 2014 - 5:16pm
tags:
Pfizer
FDA panel votes for more data before approval of AstraZeneca drug
Yahoo/Reuters
Wednesday, June 25, 2014 - 3:22pm
tags:
FDA, advisory panels, AstraZeneca, olaparib, ovarian cancer
If You Thought Eli Lilly Could be Takeover Bait, Read This…
WSJ Online
Wednesday, June 25, 2014 - 3:10pm
tags:
Eli Lilly, M&A
AbbVie CEO not ruling out hostile move on Shire
Yahoo/Reuters
Wednesday, June 25, 2014 - 10:18am
tags:
AbbVie, Pharma CEOs, Richard Gonzalez, M&A, Shire
Whistleblower to get millions for speaking up
Marketwatch
Wednesday, June 25, 2014 - 10:13am
tags:
whistleblower lawsuits, Endo Health Solutions, lidoderm
Merck targets Alzheimer's in $526M collaboration on new cognitive treatment
Fierce Pharma
Wednesday, June 25, 2014 - 7:47am
tags:
Merck, Alzheimer's disease, BNC375, Bionomics, Adelaide
FDA Ends Olmesartan Safety Review, But...
Forbes
Wednesday, June 25, 2014 - 7:45am
tags:
FDA, Olmesartan, Benicar, diabetes
Zafgen Supersizes Its Obesity-Focused IPO: An Early Investor's Reflections
Forbes
Wednesday, June 25, 2014 - 7:44am
tags:
Zafgen, obesity, IPOs
Aerie Pharma's eye drug succeeds in mid-stage trial
Yahoo/Reuters
Wednesday, June 25, 2014 - 7:43am
tags:
Aerie Pharma, Roclatan
Basilea Gets FDA Request for More Data on Pneumonia Drug
Bloomberg
Wednesday, June 25, 2014 - 7:41am
tags:
FDA, Basilea, ceftobiprole, pneumonia, antibiotics
Eli Lilly: Climbing The Hill Of Survival And Success
Seeking Alpha
Wednesday, June 25, 2014 - 7:39am
tags:
Eli Lilly
Abbvie presses case for $46 billion Shire takeover
Reuters
Wednesday, June 25, 2014 - 7:37am
tags:
AbbVie, Shire, M&A
Pharma’s Huge Bet on Immunotherapies
Motley Fool
Wednesday, June 25, 2014 - 7:35am
tags:
immunotherapy, anti-PD-1 immunotherapy, anti-PD-L1, MK-3475, Merck, nivolumab, Roche, Bristol-Myers Squibb
Report: Roche, Novartis among Swiss companies with highest pay gaps
Fierce Pharma
Tuesday, June 24, 2014 - 5:20pm
tags:
executive pay, Roche, Novartis
Big Pharma ceding sales--and share--to up-and-coming drugmakers
Fierce Pharma
Tuesday, June 24, 2014 - 5:19pm
tags:
Big Pharma
Should Reporters Have Agreed To The Vertex Embargo?
Forbes
Tuesday, June 24, 2014 - 5:17pm
tags:
Vertex Pharmaceuticals, journalists, lumacaftor, Kalydeco, cystic fibrosis
Bristol-Myers says Phase 3 study of nivolumab versus dacarbazine stopped early
Yahoo/Fly on the Wall
Tuesday, June 24, 2014 - 5:15pm
tags:
nivolumab, Bristol-Myers Squibb, dacarbazine, melanoma
Hologic's 3-D Mammogram Makes Better Breast Cancer Test, Study Says
Bloomberg
Tuesday, June 24, 2014 - 4:49pm
tags:
Hologic, 3-D mammograms, breast cancer
California biotech IPOs burgeoning, thanks in part to federal law
LA Times, CA
Tuesday, June 24, 2014 - 4:46pm
tags:
California, biotech, IPOs

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.